https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Int J Hyperthermia 2006 Jun;22(4):353-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Int J Hyperthermia 2006 Jun;22(4):353-632006-06-01 00:00:002019-02-15 08:35:28Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Int J Hyperthermia 2006 May;22(3):229-342006-05-01 00:00:002019-02-15 08:35:29Cervical cancer: radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-782005-10-24 00:00:002023-01-23 10:35:21HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-15 / Cancer 2005 Aug;104(4):763-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-15 / Cancer 2005 Aug;104(4):763-702005-08-15 00:00:002019-02-15 08:35:31First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-01 / Hum. Immunol. 2005 Jul;66(7):762-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-01 / Hum. Immunol. 2005 Jul;66(7):762-722005-07-01 00:00:002019-02-15 08:35:30Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-05-01 / Int J Hyperthermia 2005 May;21(3):193-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-05-01 / Int J Hyperthermia 2005 May;21(3):193-72005-05-01 00:00:002019-02-15 08:35:32Editorial: clinical hyperthermia combined with radiation is safe
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3485-500
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Curr. Pharm. Des. 2005;11(27):3485-5002005-01-01 00:00:002019-02-15 08:35:34Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-12-01 / Gynecol. Oncol. 2004 Dec;95(3):680-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-12-01 / Gynecol. Oncol. 2004 Dec;95(3):680-52004-12-01 00:00:002019-02-15 08:35:32Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-09-01 / Anticancer Res. 2003 Sep-Oct;23(5b):4293-303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-09-01 / Anticancer Res. 2003 Sep-Oct;23(5b):4293-3032003-09-01 00:00:002019-02-15 08:45:51Dendritic cell-based vaccines in breast and gynaecologic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-07-30 / J. Cancer Res. Clin. Oncol. 2003 Sep;129(9):521-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-07-30 / J. Cancer Res. Clin. Oncol. 2003 Sep;129(9):521-302003-07-30 00:00:002019-02-15 08:35:35Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients
